持续应对COPD国际患者调查：12个国家COPD的经济影响

数据集获取（Figshare）

• 源站标题：Continuing to Confront COPD International Patient Survey: Economic Impact of COPD in 12 Countries
• DOI：10.1371/journal.pone.0152618
• 发布日期：2016-04-19
• 文件数：2 个
• 文件总体积：588.83 KB
• 源站页面：https://plos.figshare.com/articles/dataset/Continuing_to_Confront_COPD_International_Patient_Survey_Economic_Impact_of_COPD_in_12_Countries/3185362

命令行下载

curl -L -o "S1 Fig.TIF" "https://ndownloader.figshare.com/files/4971343"
curl -L -o "S1 Supporting Information.DOCX" "https://ndownloader.figshare.com/files/4971346"

文件清单

• S1 Fig.TIF（552.42 KB）
• S1 Supporting Information.DOCX（36.41 KB）

文件总体积 588.83 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Background
The Continuing to Confront COPD International Patient Survey estimated the prevalence and burden of COPD across 12 countries. Using data from this survey we evaluated the economic impact of COPD.
Methods
This cross-sectional, population-based survey questioned 4,343 subjects aged 40 years and older, fulfilling a case definition of COPD based on self-reported physician diagnosis or symptomatology. Direct cost measures were based on exacerbations of COPD (treated and those requiring emergency department visits and/or hospitalisation), contacts with healthcare professionals, and COPD medications. Indirect costs were calculated from work loss values using the Work Productivity and Activity Impairment scale. Combined direct and indirect costs estimated the total societal costs per patient.
Results
The annual direct costs of COPD ranged from $504 (South Korea) to $9,981 (USA), with inpatient hospitalisations (5 countries) and home oxygen therapy (3 countries) being the key drivers of direct costs. The proportion of patients completely prevented from working due to their COPD ranged from 6% (Italy) to 52% (USA and UK) with 8 countries reporting this to be ≥20%. Total societal costs per patient varied widely from $1,721 (Russia) to $30,826 (USA) but a consistent pattern across countries showed greater costs among those with increased burden of COPD (symptoms, health status and more severe disease) and a greater number of comorbidities.
Conclusions
The economic burden of COPD is considerable across countries, and requires targeted resources to optimise COPD management encompassing the control of symptoms, prevention of exacerbations and effective treatment of comorbidities. Strategies to allow COPD patients to remain in work are important for addressing the substantial wider societal costs.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.1371/journal.pone.0152618（source: https://plos.figshare.com/articles/dataset/Continuing_to_Confront_COPD_International_Patient_Survey_Economic_Impact_of_COPD_in_12_Countries/3185362）。